{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:39:25Z","timestamp":1794724765595,"version":"4.9.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370095"],"award-info":[{"award-number":["82370095"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170105"],"award-info":[{"award-number":["82170105"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400119"],"award-info":[{"award-number":["82400119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82200113"],"award-info":[{"award-number":["No. 82200113"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NO.82400119"],"award-info":[{"award-number":["NO.82400119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82300123"],"award-info":[{"award-number":["No.82300123"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tumor necrosis factor receptor 2-positive regulatory T (TNFR2\n                    <jats:sup>+<\/jats:sup>\n                    T\n                    <jats:sub>reg<\/jats:sub>\n                    ) cells, the most suppressive subset of T\n                    <jats:sub>reg<\/jats:sub>\n                    cells, are enriched in malignant pleural effusion (MPE), contributing to disease progression. However, the underlying mechanisms responsible for their accumulation remain unclear. Here we demonstrate that the C\u2013X\u2013C motif chemokine ligand 16 (CXCL16)\/C\u2013X\u2013C chemokine receptor type 6 (CXCR6) axis plays a critical role in recruiting TNFR2\n                    <jats:sup>+<\/jats:sup>\n                    T\n                    <jats:sub>reg<\/jats:sub>\n                    cells to MPE, with cancer-associated fibroblasts serving as the primary source of CXCL16. Mechanistically, under the hypoxic conditions prevailing in the pleural cavity, cancer-associated fibroblasts in MPE undergo glycolysis, which in turn leads to an increase in the production of endogenous lactate. This elevated lactate induces histone H3 lysine 18 lactylation (H3K18la) at the promoter regions of both the CXCL16 gene and its transcription factor forkhead box O3 (FOXO3), which may contribute to CXCL16 transcription. TNFR2\n                    <jats:sup>+<\/jats:sup>\n                    T\n                    <jats:sub>reg<\/jats:sub>\n                    cells that express high levels of CXCR6, the only receptor for CXCL16, are subsequently recruited into MPE. The infiltration of TNFR2\n                    <jats:sup>+<\/jats:sup>\n                    T\n                    <jats:sub>reg<\/jats:sub>\n                    cells may reinforce the immunosuppressive milieu of MPE, facilitating disease progression. Collectively, these findings uncover a novel mechanism governing immunosuppression in MPE, providing new insights into potential therapeutic strategies to disrupt this process.\n                  <\/jats:p>","DOI":"10.1038\/s12276-025-01557-3","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T01:25:24Z","timestamp":1764293124000},"page":"2671-2685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["H3K18 lactylation in cancer-associated fibroblasts drives malignant pleural effusion progression via TNFR2+ Treg recruitment"],"prefix":"10.1038","volume":"57","author":[{"given":"Linlin","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"1557_CR1","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.amjmed.2022.04.017","volume":"135","author":"S Gayen","year":"2022","unstructured":"Gayen, S. Malignant pleural effusion: presentation, diagnosis, and management. Am. J. Med. 135, 1188\u20131192 (2022).","journal-title":"Am. J. Med."},{"key":"1557_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1183\/16000617.0019-2016","volume":"25","author":"I Psallidas","year":"2016","unstructured":"Psallidas, I., Kalomenidis, I., Porcel, J. M., Robinson, B. W. & Stathopoulos, G. T. Malignant pleural effusion: from bench to bedside. Eur. Respir. Rev. 25, 189\u2013198 (2016).","journal-title":"Eur. Respir. Rev."},{"key":"1557_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pccm.2022.11.001","volume":"1","author":"L Wang","year":"2023","unstructured":"Wang, L., Jia, Q., Chu, Q. & Zhu, B. Targeting tumor microenvironment for non-small cell lung cancer immunotherapy. Chin. Med J. Pulm. Crit. Care Med. 1, 18\u201329 (2023).","journal-title":"Chin. Med J. Pulm. Crit. Care Med."},{"key":"1557_CR4","doi-asserted-by":"publisher","first-page":"e1554969","DOI":"10.1080\/2162402X.2018.1554969","volume":"8","author":"P Murthy","year":"2019","unstructured":"Murthy, P. et al. Making cold malignant pleural effusions hot: driving novel immunotherapies. Oncoimmunology 8, e1554969 (2019).","journal-title":"Oncoimmunology"},{"key":"1557_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.canlet.2020.12.016","volume":"500","author":"FS Yi","year":"2021","unstructured":"Yi, F. S., Zhai, K. & Shi, H. Z. Helper T cells in malignant pleural effusion. Cancer Lett. 500, 21\u201328 (2021).","journal-title":"Cancer Lett."},{"key":"1557_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1465-9921-12-77","volume":"12","author":"ZJ Ye","year":"2011","unstructured":"Ye, Z. J. et al. CD39+ regulatory T cells suppress generation and differentiation of Th17 cells in human malignant pleural effusion via a LAP-dependent mechanism. Respir. Res. 12, 77 (2011).","journal-title":"Respir. Res."},{"key":"1557_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11596-013-1066-2","volume":"33","author":"WB Yang","year":"2013","unstructured":"Yang, W. B., Ye, Z. J., Xiang, F., Zhang, J. C. & Zhou, Q. Th17\/Treg imbalance in malignant pleural effusion. J. Huazhong Univ. Sci. Technol. Med Sci. 33, 27\u201332 (2013).","journal-title":"J. Huazhong Univ. Sci. Technol. Med Sci."},{"key":"1557_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4049\/jimmunol.179.1.154","volume":"179","author":"X Chen","year":"2007","unstructured":"Chen, X., B\u00e4umel, M., M\u00e4nnel, D. N., Howard, O. M. & Oppenheim, J. J. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J. Immunol. 179, 154\u2013161 (2007).","journal-title":"J. Immunol."},{"key":"1557_CR9","doi-asserted-by":"crossref","unstructured":"Chen, X. & Oppenheim, J. J. Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer. Sci. Signal. 10, eaal2328 (2017).","DOI":"10.1126\/scisignal.aal2328"},{"key":"1557_CR10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4049\/jimmunol.0903548","volume":"185","author":"X Chen","year":"2010","unstructured":"Chen, X. et al. Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3\u2212 conventional T cells to suppression by CD4+FoxP3+ regulatory T cells. J. Immunol. 185, 174\u2013182 (2010).","journal-title":"J. Immunol."},{"key":"1557_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.clim.2013.07.003","volume":"149","author":"C Govindaraj","year":"2013","unstructured":"Govindaraj, C. et al. Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment. Clin. Immunol. 149, 97\u2013110 (2013).","journal-title":"Clin. Immunol."},{"key":"1557_CR12","doi-asserted-by":"crossref","unstructured":"Tam, E. M. et al. Antibody-mediated targeting of TNFR2 activates CD8+ T cells in mice and promotes antitumor immunity. Sci. Transl. Med. 11, eaax0720 (2019).","DOI":"10.1126\/scitranslmed.aax0720"},{"key":"1557_CR13","doi-asserted-by":"crossref","unstructured":"Nie, Y. et al. Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer. Sci. Signal. 11, eaan0790 (2018).","DOI":"10.1126\/scisignal.aan0790"},{"key":"1557_CR14","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.21037\/atm-20-7181","volume":"8","author":"LL Ye","year":"2020","unstructured":"Ye, L. L. et al. Accumulation of TNFR2-expressing regulatory T cells in malignant pleural effusion of lung cancer patients is associated with poor prognosis. Ann. Transl. Med. 8, 1647 (2020).","journal-title":"Ann. Transl. Med."},{"key":"1557_CR15","doi-asserted-by":"crossref","unstructured":"Xue, Q. et al. Lactylation-driven TNFR2 expression in regulatory T cells promotes the progression of malignant pleural effusion. J. Immunother. Cancer 12, e010040 (2024).","DOI":"10.1136\/jitc-2024-010040"},{"key":"1557_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00608-8","volume":"8","author":"M Zhang","year":"2024","unstructured":"Zhang, M. et al. CCL11\/CCR3-dependent eosinophilia alleviates malignant pleural effusions and improves prognosis. NPJ Precis. Oncol. 8, 138 (2024).","journal-title":"NPJ Precis. Oncol."},{"key":"1557_CR17","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3892\/or.2014.3576","volume":"33","author":"G Yang","year":"2015","unstructured":"Yang, G. et al. Treg\/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis. Oncol. Rep. 33, 478\u2013484 (2015).","journal-title":"Oncol. Rep."},{"key":"1557_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cytogfr.2022.07.006","volume":"67","author":"X Xiang","year":"2022","unstructured":"Xiang, X. et al. Cancer-associated fibroblasts: vital suppressors of the immune response in the tumor microenvironment. Cytokine Growth Factor Rev. 67, 35\u201348 (2022).","journal-title":"Cytokine Growth Factor Rev."},{"key":"1557_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen, Z., Han, F., Du, Y., Shi, H. & Zhou, W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct. Target. Ther. 8, 70 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1557_CR20","doi-asserted-by":"crossref","unstructured":"Korbecki, J. et al. The effect of hypoxia on the expression of CXC chemokines and CXC chemokine receptors\u2014a review of literature. Int. J. Mol. Sci. 22, 843 (2021).","DOI":"10.3390\/ijms22020843"},{"key":"1557_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575\u2013580 (2019).","journal-title":"Nature"},{"key":"1557_CR22","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","volume":"82","author":"J Xiong","year":"2022","unstructured":"Xiong, J. et al. Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol. Cell 82, 1660\u20131677 (2022).","journal-title":"Mol. Cell"},{"key":"1557_CR23","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.immuni.2024.04.006","volume":"57","author":"A De Leo","year":"2024","unstructured":"De Leo, A. et al. Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma. Immunity 57, 1105\u20131123 (2024).","journal-title":"Immunity"},{"key":"1557_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.12","volume":"1","author":"Y Ren","year":"2022","unstructured":"Ren, Y. et al. Majorbio Cloud: A one-stop, comprehensive bioinformatic platform for multiomics analyses. iMeta 1, e12 (2022).","journal-title":"iMeta"},{"key":"1557_CR25","doi-asserted-by":"crossref","unstructured":"Zhang, S. et al. C1q+tumor-associated macrophages contribute to immunosuppression through fatty acid metabolic reprogramming in malignant pleural effusion. J. Immunother. Cancer 11, e007441 (2023).","DOI":"10.1136\/jitc-2023-007441"},{"key":"1557_CR26","doi-asserted-by":"crossref","unstructured":"Kureshi, C. T. & Dougan, S. K. Cytokines in cancer. Cancer Cell 43, 15\u221235 (2024).","DOI":"10.1016\/j.ccell.2024.11.011"},{"key":"1557_CR27","doi-asserted-by":"crossref","unstructured":"Mempel, T. R., Lill, J. K. & Altenburger, L. M. How chemokines organize the tumour microenvironment. Nat. Rev. Cancer 24, 28\u201350 (2023).","DOI":"10.1038\/s41568-023-00635-w"},{"key":"1557_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1165\/rcmb.2018-0201OC","volume":"61","author":"XS Wei","year":"2019","unstructured":"Wei, X. S. et al. IL-17A-producing \u03b3\u03b4T cells inhibit the formation of malignant pleural effusions. Am. J. Respir. Cell Mol. Biol. 61, 174\u2013184 (2019).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"1557_CR29","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s12035-022-03193-8","volume":"60","author":"MT Ibarra-Guti\u00e9rrez","year":"2023","unstructured":"Ibarra-Guti\u00e9rrez, M. T., Serrano-Garc\u00eda, N. & Orozco-Ibarra, M. Rotenone-induced model of Parkinson\u2019s disease: beyond mitochondrial complex I inhibition. Mol. Neurobiol. 60, 1929\u20131948 (2023).","journal-title":"Mol. Neurobiol."},{"key":"1557_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","volume":"20","author":"W Li","year":"2024","unstructured":"Li, W. et al. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy 20, 114\u2013130 (2024).","journal-title":"Autophagy"},{"key":"1557_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02775-y","volume":"23","author":"E Galle","year":"2022","unstructured":"Galle, E. et al. H3K18 lactylation marks tissue-specific active enhancers. Genome Biol. 23, 207 (2022).","journal-title":"Genome Biol."},{"key":"1557_CR32","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.cell.2024.04.002","volume":"187","author":"Z Zong","year":"2024","unstructured":"Zong, Z. et al. Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis. Cell 187, 2375\u20132392 (2024).","journal-title":"Cell"},{"key":"1557_CR33","doi-asserted-by":"crossref","unstructured":"Ju, J. et al. The alanyl-tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer. J. Clin. Invest. 134, e174587 (2024).","DOI":"10.1172\/JCI174587"},{"key":"1557_CR34","doi-asserted-by":"crossref","unstructured":"Li, H. et al. AARS1 and AARS2 sense L-lactate to regulate cGAS as global lysine lactyltransferases. Nature 634, 1229\u20131237 (2024).","DOI":"10.1038\/s41586-024-07992-y"},{"key":"1557_CR35","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/ijc.33873","volume":"150","author":"Y Qu","year":"2022","unstructured":"Qu, Y. et al. The effects of TNF-\u03b1\/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer. Int. J. Cancer 150, 1373\u20131391 (2022).","journal-title":"Int. J. Cancer"},{"key":"1557_CR36","doi-asserted-by":"crossref","unstructured":"Jiang, M. et al. MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2. J. Immunother. Cancer 10, e005241 (2022).","DOI":"10.1136\/jitc-2022-005241"},{"key":"1557_CR37","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.molmed.2017.09.007","volume":"23","author":"\u00c9S Vanamee","year":"2017","unstructured":"Vanamee, \u00c9S. & Faustman, D. L. TNFR2: a novel target for cancer immunotherapy. Trends Mol. Med. 23, 1037\u20131046 (2017).","journal-title":"Trends Mol. Med."},{"key":"1557_CR38","doi-asserted-by":"crossref","unstructured":"Zvi, G. F. et al. Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils. PLoS ONE 7, e31524 (2012).","DOI":"10.1371\/journal.pone.0031524"},{"key":"1557_CR39","doi-asserted-by":"crossref","unstructured":"Shujing, W. et al. Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance. NPJ Precis Oncol. 8, 31 (2024).","DOI":"10.1038\/s41698-024-00522-z"},{"key":"1557_CR40","doi-asserted-by":"crossref","unstructured":"Zhengjun, Z. et al. Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3. J. Immunother. Cancer 9, e001946 (2021).","DOI":"10.1136\/jitc-2020-001946"},{"key":"1557_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27026-9","volume":"12","author":"ZY Huang","year":"2021","unstructured":"Huang, Z. Y. et al. Single-cell analysis of diverse immune phenotypes in malignant pleural effusion. Nat. Commun. 12, 6690 (2021).","journal-title":"Nat. Commun."},{"key":"1557_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101059","volume":"73","author":"F Li","year":"2024","unstructured":"Li, F. et al. Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer. Drug Resist. Update 73, 101059 (2024).","journal-title":"Drug Resist. Update"},{"key":"1557_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02008-9","volume":"23","author":"F Li","year":"2024","unstructured":"Li, F. et al. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma. Mol. Cancer 23, 90 (2024).","journal-title":"Mol. Cancer"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01557-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01557-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01557-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:02:49Z","timestamp":1765296169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01557-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["1557"],"URL":"https:\/\/doi.org\/10.1038\/s12276-025-01557-3","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was approved by the Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology ([2024] IACUC Number: 0990). All animal experiments were approved by the Committee on Ethics of Animal Experiments at the Tongji Medical College of Huazhong University of Science and Technology ([2022] IACUC Number: 4112).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}